APRIL 15, 2006
VOLUME 3 NO. 7

EDITORIAL

In with the new, but keep the old too


Canadians are a well-mannered bunch. We don't show up for dinner empty handed and we don't let a patient leave our office empty-handed. It would seem rude and uncaring after they've come all this way and waited so long....

The prescription seals the deal, says Chicago geriatrician Dr Holly Holmes. The framework she and her colleagues developed to help doctors decide when a medication is no longer necessary for a given patient appears this month in the Archives of Internal Medicine (see "Know when it's time to nix an Rx"). Dr Holmes' mission is a tough one. Refusing to write a new script isn't enough, she says — though antibiotic over-prescribing is largely being curbed this way. Dr Holmes says it's time for physicians to put a stop on a prescription the patient may have been refilling since, well before the doc was a doc. The antibiotic resistance message that worked so well to appease patients sent home to their chicken soup won't work here. The reason you should refuse a refill is a little harder to justify: the patient's too old or too sick to benefit from therapy anymore.

Drugs that are taken longterm to treat risk factors or chronic conditions present many dilemmas for equitable and affordable healthcare. Doctors need better strategies to assess what level of benefit justifies keeping a patient on a drug. They could also do with some tools more humane than actuarial tables to help them talk about it with their patients. With better information it may be one of those decisions that patients can make for themselves.

It's a dilemma that also plays out in provincial formulary committees that decide which drugs will be covered. There have been many calls for a strategy to remove older drugs from the listing to make room for new drugs, but as yet very little has been done. The challenge of weeding out older and less effective therapies has been left to doctors dealing with one change-resistant patient at a time to replace one medication with another. The conservatism seen in family physicians about adopting new therapies (see "Add a new drug to your arsenal" on page 16) may be far more situational than inherent. — Susan Usher, health policy editor

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.